These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 24461301

  • 1. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E, Perricone G, D'Amico M, Tinè F, D'Amico G.
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.
    Li T, Ke W, Sun P, Chen X, Belgaumkar A, Huang Y, Xian W, Li J, Zheng Q.
    BMJ Open; 2016 May 04; 6(5):e010902. PubMed ID: 27147389
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N, Motola-Kuba M, Candia R, Arrese M, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC.
    Ann Hepatol; 2014 May 04; 13(4):420-8. PubMed ID: 24927613
    [Abstract] [Full Text] [Related]

  • 4. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul 04; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 5. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L, Bendtsen F, Hansen EF, Møller S.
    Dig Liver Dis; 2014 Mar 04; 46(3):251-6. PubMed ID: 24290869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
    Fierbinteanu-Braticevici C, Udeanu M, Dragomir P, Andronescu D.
    Rom J Intern Med; 2003 Mar 04; 41(3):247-54. PubMed ID: 15526508
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A, Hernández-Gea V, Bosch J.
    Hepatol Int; 2018 Feb 04; 12(Suppl 1):68-80. PubMed ID: 29210030
    [Abstract] [Full Text] [Related]

  • 12. The role of carvedilol in the management of portal hypertension.
    Tripathi D, Hayes PC.
    Eur J Gastroenterol Hepatol; 2010 Aug 04; 22(8):905-11. PubMed ID: 20093937
    [Abstract] [Full Text] [Related]

  • 13. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.
    Tripathi D, Therapondos G, Lui HF, Stanley AJ, Hayes PC.
    Aliment Pharmacol Ther; 2002 Mar 04; 16(3):373-80. PubMed ID: 11876689
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of carvedilol for the treatment of portal hypertension.
    Hemstreet BA.
    Pharmacotherapy; 2004 Jan 04; 24(1):94-104. PubMed ID: 14740791
    [Abstract] [Full Text] [Related]

  • 15. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T, Sekiyama T, Katsuta Y, Kurokawa H, Komeichi H, Tsutsui H, Terada H, Ohsuga M, Satomura K, Okumura H.
    J Hepatol; 1992 May 04; 15(1-2):48-53. PubMed ID: 1354676
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD.
    Am J Gastroenterol; 2004 Oct 04; 99(10):1953-8. PubMed ID: 15447755
    [Abstract] [Full Text] [Related]

  • 18. An advance in the treatment of portal hypertension?
    Wong F, Blendis L.
    Gastroenterology; 2000 Apr 04; 118(4):802-3. PubMed ID: 10734033
    [No Abstract] [Full Text] [Related]

  • 19. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
    Shah HA, Azam Z, Rauf J, Abid S, Hamid S, Jafri W, Khalid A, Ismail FW, Parkash O, Subhan A, Munir SM.
    J Hepatol; 2014 Apr 04; 60(4):757-64. PubMed ID: 24291366
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.